Universal Technical Institute (UTI) Q2 2026 earnings review
Topline Keeps Growing, But Growth Investments Wipe Out Profits
Universal Technical Institute (UTI) is executing a massive expansion, but the cost of building the future is severely eating the present. Revenue grew 6.7% YoY to $221.4M, marking a decelerating but stable topline. However, profits are violently reversing. Net Income plummeted 96% to just $0.4M, and Adjusted EBITDA cratered 51% to $14.1M. Management attributes this entire profit wipeout to $11M in 'strategic growth expenses' required for their North Star Phase II campus expansions. While student starts accelerated (+13.8% YoY), the company is asking investors to stomach deep near-term margin compression and negative free cash flow for the promise of a massive FY2027-2029 payoff. Reaffirmed guidance shows management is not backing down from this aggressive strategy.
🐂 Bull Case
New student starts grew 13.8% YoY to 7,569, an impressive acceleration from Q1's 2.6% growth. The core demand engine is highly functional and responding well to recent marketing investments.
The new UTI San Antonio campus opened 60% above initial enrollment plans. If Atlanta follows suit, the massive upfront CapEx will transform into high-margin recurring revenue by FY2027.
🐻 Bear Case
Operating margin fell to nearly zero (0.2%). The heavy toll of expansion is dragging down the entire enterprise, leaving essentially zero room for error if student enrollment targets are missed.
With capital expenditures soaring 178% YoY to $30.4M for the quarter, Adjusted Free Cash Flow was severely negative at $(25.0)M. The company is leaning heavily on its balance sheet to fund this growth.
⚖️ Verdict: ⚪
Neutral. The topline and enrollment metrics prove the demand is there, but the sheer velocity of margin degradation introduces immense execution risk. Investors must trade near-term earnings for long-term scale.
Key Themes
Concorde Segment Profitability Cratering
Management cites strong demand across the board, but the Concorde (Healthcare) segment's profitability is reversing alarmingly. Despite revenue growing 7.5% YoY, Concorde's Adjusted EBITDA fell 62% in absolute dollars (from $5.8M to $2.2M), and margins collapsed to just 2.7%. This casts doubt on the segment's operating leverage during this heavy investment cycle.
Accelerating Student Starts
After a sluggish Q1 where starts grew only 2.6%, Q2 saw new student starts accelerating aggressively to 13.8% YoY growth (7,569 total starts). This was crucial to validate management's narrative that the demand funnel remains robust and justifies the massive infrastructure build-out.
Free Cash Flow Deep in the Red
Adjusted Free Cash Flow is reversing rapidly into negative territory, hitting $(25.0)M in Q2 (down 129% YoY). Driven by a massive 178% YoY spike in quarterly CapEx ($30.4M) for new facilities. While liquidity is ample at $202.4M, the cash burn is intense and requires flawless execution on new campus ramps to replenish the balance sheet.
North Star Phase II Execution
The company's specific infrastructure rollout is hitting milestones. The UTI San Antonio campus opened in March with starts 60% above plan. UTI Atlanta is tracking ahead of its July start. The physical expansion footprint is directly converting into enrollment beats.
AI and Data Center Infrastructure Tailwinds
Management explicitly tied their curriculum value to macro technology trends. CEO Jerome Grant highlighted that AI advancements are driving massive construction of data centers and energy systems, which in turn accelerates demand for the exact skilled trades UTI provides. This positions UTI as a secondary beneficiary of the AI infrastructure boom.
Operating Leverage is Moving in the Wrong Direction
Selling, General and Administrative (SG&A) expenses are accelerating faster than sales. SG&A grew 17.6% YoY to $103.6M, far outpacing the 6.7% revenue growth. While part of this is planned 'growth expense,' it highlights a business model that currently lacks efficiency and scale benefits.
Other KPIs
Accelerating dramatically. Up 178% YoY from $10.9M in 25Q2. This massive outflow is the direct manifestation of the North Star Phase II strategy, pouring cash into physical real estate and equipment for new campuses. YTD CapEx sits at $52.7M, tracking toward the ~$100M annual target.
Stable. Consists of $87.2M in cash, $74.8M in short-term investments, and $40.4M on the revolver. Despite heavy cash burn, the balance sheet retains enough cushion to fund the remaining FY26 growth investments without immediate dilution risk.
Guidance
Stable. Management reaffirmed guidance. The midpoint ($910M) implies an 8.8% YoY growth rate over FY25's $835.6M. With H1 revenue at $442.2M, the company needs roughly $468M in H2, implying an acceleration in the back half of the year driven by the new campus openings.
Stable. Guidance was reaffirmed, implying a 7.9% YoY deceleration from FY25's $126.5M. With only $41.3M achieved in H1, the company is baking in a steep re-acceleration to ~$75M in H2 to hit the midpoint. This puts massive pressure on Q3 and Q4 execution.
Stable. Reaffirmed. Achieving this relies heavily on massive operating cash inflows in H2, as YTD Adjusted FCF is deeply negative at $(44.2)M. Management is implicitly promising a dramatic cash flow inflection over the next six months.
Key Questions
Concorde Segment De-leverage
Concorde revenue grew 7.5%, but Adjusted EBITDA dropped 62%. What specific expenses drove this disproportionate margin collapse in the healthcare segment, and when do you expect operating leverage to return?
H2 Adjusted EBITDA Ramp
To hit the midpoint of your FY26 Adjusted EBITDA guidance, you need to generate roughly $75M in H2 compared to just $41M in H1. Walk us through the specific cost roll-offs and revenue catalysts that make this steep H2 ramp achievable.
Free Cash Flow Inflection
With YTD Adjusted Free Cash Flow at negative $44M, achieving your $20M-$25M positive full-year guidance requires a $65M+ swing in the next six months. Is this purely driven by the timing of CapEx, or are there significant working capital tailwinds expected?